Intact Parathyroid Hormone (iPTH) Assay: An Early Approach for Bone Health Assessment in Chronic Renal Failure
The level of iPTH was significantly increased from Stage 2 onwards; hence, it can be used as a diagnostic marker of CKD-MBD from the initial stages. Subsequent to diagnosis, the progression of CKD-MBD can be prevented by choosing the appropriate intervention from the wide array of treatment options available.
Authors
- Ravi Shekhar (ORCID: https://orcid.org/0000-0002-6609-1932)
- Dilip Kumar (ORCID: https://orcid.org/0000-0003-4858-8440)
- Prit Pal Singh (ORCID: https://orcid.org/0000-0003-4600-1693)
- Santosh Kumar (ORCID: https://orcid.org/0000-0002-6195-1913)
- Sweta Kumari (ORCID: https://orcid.org/0000-0002-1286-2375)
- Naresh Kumar
Institutions
- Indira Gandhi Institute of Medical Sciences (IN)
Publication Details
- Journal
- Cureus
- Published
- 2024-10-27
- DOI
- https://doi.org/10.7759/cureus.72510
- Citations
- 2
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.68